Skip to main navigation

Investor Relations

Home
Investors & Media
Contact Us
Careers

Overview
News / Events
Financial
- Annual Reports & Proxies
- Financial Results
Stock
SEC Filings
- All SEC Filings
Corporate Governance

Overview
News / Events
Financial
- Annual Reports & Proxies
- Financial Results
Stock
SEC Filings
- All SEC Filings
Corporate Governance

Financial Results

Show all

2025

Q3

BioXcel Therapeutics Reports Third Quarter 2025 Financial Results
Form 10-Q

Q2

BioXcel Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Updates
Form 10-Q

Q1

BioXcel Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
Form 10-Q

2024

Q4

BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2024
Form 10-K

Q3

BioXcel Therapeutics Reports Third Quarter 2024 Financial Results
Form 10-Q

Q2

BioXcel Therapeutics Reports Second Quarter 2024 Financial Results
Form 10-Q

Q1

BioXcel Therapeutics Reports First Quarter 2024 Financial Results
Form 10-Q

2023

Q4

BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2023
Form 10-K

Q3

BioXcel Therapeutics Aligns with FDA Recommendation for Phase 3 Trial for TRANQUILITY Program, Provides Update on Strategic Financing, and Reports Third Quarter 2023 Financial Results
Form 10-Q

Q2

BioXcel Therapeutics Reports Second Quarter 2023 Financial Results and Announces Strategic Reprioritization
Form 10-Q

Q1

BioXcel Therapeutics Reports First Quarter 2023 Financial Results and Recent Operational Highlights
Form 10-Q

2022

Q4

BioXcel Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Operational Highlights
Form 10-K

Q3

BioXcel Therapeutics Reports Third Quarter 2022 Financial Results and Recent Operational Highlights
Form 10-Q

Q2

BioXcel Therapeutics Reports Second Quarter 2022 Financial Results and Recent Operational Highlights
Form 10-Q

Q1

BioXcel Therapeutics Reports First Quarter 2022 Financial Results and Recent Operational Highlights
Form 10-Q

2021

Q4

BioXcel Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Operational Highlights
Form 10-K

Q3

BioXcel Therapeutics Reports Third Quarter 2021 Financial Results and Recent Operational Highlights

Q2

Earnings Release
10-Q

Q1

Earnings Release
10-Q

2020

Q4

Earnings Release 84 KB
Earnings Webcast
10-K

Q3

Earnings Release 81.7 KB
Earnings Webcast
10-Q

Q2

Earnings Release 98.9 KB
10-Q

Q1

Earnings Release 91.6 KB
Earnings Webcast
10-Q

2019

Q4

Earnings Release 90.2 KB
Earnings Webcast
10-K
Annual Report 4.5 MB

Q3

Earnings Release 86.8 KB
Earnings Webcast
10-Q

Q2

Earnings Release 87.6 KB
Earnings Webcast
10-Q

Q1

Earnings Release 84 KB
Earnings Webcast
10-Q

2018

Q4

Earnings Release 88.3 KB
Earnings Webcast
10-K

Q3

Earnings Release 68.1 KB
Earnings Webcast
10-Q

Q2

Earnings Release 73.6 KB
Earnings Webcast
10-Q

Q1

Earnings Release 67.9 KB
10-Q

Site - Investor Tools

Print Page

Tear Sheet

Email Alerts

RSS Feeds

Contacts

Search

About Us
Our Products
Our Pipeline
Our Science
Patients & Advocacy

Home
Investors & Media
Contact Us
Careers

Copyright © 2026 BioXcel Therapeutics, Inc. All Rights Reserved.

Privacy Policy
Disclaimer
Sitemap